Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab

Eur J Rheumatol. 2019 May 20;6(3):150-152. doi: 10.5152/eurjrheum.2019.17169. Print 2019 Jul.

Abstract

Systemic lupus erythematosus (SLE) is characterized by a wide variety of manifestations and a difficult disease control in some patients. We present the case of a 51-year-old woman who presented with a flare of SLE including arthritis and pleuropericarditis that responded to neither leflunomide, methotrexate, nor high doses of prednisone. After initiating treatment with belimumab, the patient experienced a quick and notorious improvement. She remains stable to this day while continuing belimumab therapy.

Publication types

  • Review